Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid

Author： Fulton R.W.   Step D.L.   Ridpath J.F.   Saliki J.T.   Confer A.W.   Johnson B.J.   Briggs R.E.   Hawley R.V.   Burge L.J.   Payton M.E.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.21, 2003-06, pp. : 2980-2985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge

By Dean H.J.   Leyh R.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1117-1124

Elsevier

Access to resources Recommend Favorite

Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140

By Fulton R.W.   Confer A.W.   Burge L.J.   Perino L.J.   d'Offay J.M.   Payton M.E.   Mock R.E.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 725-733

Elsevier

Access to resources Recommend Favorite

The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves

By West K.   Petrie L.   Konoby C.   Haines D.M.   Cortese V.   Ellis J.A.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 907-919

Elsevier

Access to resources Recommend Favorite

An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2

By Makoschey B.   Janssen M.G.J.   Vrijenhoek M.P.   Korsten J.H.M.   Marel P.v.d.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3261-3268

Elsevier

Access to resources Recommend Favorite

Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production

By Woolums A.R.   Siger L.   Johnson S.   Gallo G.   Conlon J.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1158-1164

Elsevier

Access to resources Recommend Favorite